Publikationen (174) Publikationen von TOMAS M. M. GARCIA-CABALLERO PARADA

2024

  1. Edoxaban treatment in a post-infarction experimental model

    European Journal of Pharmacology, Vol. 962

2023

  1. Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans

    Journal of Endocrinological Investigation

  2. Immunohistological study of the density and distribution of human penile neural tissue: gradient hypothesis

    International Journal of Impotence Research, Vol. 35, Núm. 3, pp. 286-305

  3. Modification of the Marmarou and Foda model of diffuse axonal injury (DAI) improves percentage survival of rats at 24 h and increases the amount of DAI identified

    Journal of Forensic Sciences, Vol. 68, Núm. 4, pp. 1228-1236

2022

  1. A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Silver Clusters of Five Atoms as Highly Selective Antitumoral Agents Through Irreversible Oxidation of Thiols

    Advanced Functional Materials, Vol. 32, Núm. 29

  3. The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure

    Cells, Vol. 11, Núm. 8

  4. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

    Frontiers in Pharmacology, Vol. 13

2021

  1. Correction to: Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2‑positive breast cancer? (Virchows Archiv, (2021), 479, 4, (853-857), 10.1007/s00428-021-03104-7)

    Virchows Archiv

  2. Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?

    Virchows Archiv, Vol. 479, Núm. 4, pp. 853-857

  3. PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: Summary of an expert round-table discussion

    Future Oncology, Vol. 17, Núm. 10, pp. 1209-1218

  4. POU1F1 transcription factor induces metabolic reprogramming and breast cancer progression via LDHA regulation

    Oncogene, Vol. 40, Núm. 15, pp. 2725-2740

2020

  1. An energy restriction-based weight loss intervention is able to reverse the effects of obesity on the expression of liver tumor-promoting genes

    FASEB Journal, Vol. 34, Núm. 2, pp. 2312-2325

  2. Atlas de histología: microscopía óptica y electrónica

    Editorial Universidad de Sevilla

  3. Author Correction: Identification and characterization of Cardiac Glycosides as senolytic compounds (Nature Communications, (2019), 10, 1, (4731), 10.1038/s41467-019-12888-x)

    Nature Communications

  4. Laser-induced transient skin disruption to enhance cutaneous drug delivery

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 156, pp. 165-175

  5. Looking for a better characterization of triple-negative breast cancer by means of circulating tumor cells

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2019

  1. Context-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to Pluripotency

    Stem Cell Reports, Vol. 12, Núm. 5, pp. 1099-1112

  2. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats

    Biochemical Pharmacology, Vol. 170

  3. Identification and characterization of Cardiac Glycosides as senolytic compounds

    Nature Communications, Vol. 10, Núm. 1